Feraheme® (ferumoxytol) Injection For Intravenous (IV)use

References

 

  1. National Kidney Foundation. Anemia and chronic kidney disease: stages 1–4 [patient brochure]. www.kidney.org/atoz/pdf/anemia.pdf. Accessed September 1, 2008.
  2. National Kidney Foundation. Iron and Chronic Kidney Disease: What You Need to Know. 2008:1-12.
  3. National Kidney Foundation. Hemodialysis: what you need to know. 2006-2007:1-24. 4.
  4. National Kidney Foundation KDOQI clinical practice guidelines for chronic kidney disease: evaluation, classification, and stratification. http://www.kidney.org/professionals/kdoqi/guidelines_ckd/p4_class_g1.htm. Accessed June 2, 2009.
  5. National Kidney Foundation. Glomerular filtration rate (GFR) http://www.kidney.org/atoz/content/gfr.cfm. Accessed September 1, 2008.
  6. Nurko S. Anemia in chronic kidney disease: causes, diagnosis, treatment. Cleve Clin J Med. 2006;73(3):289-297.2006;73(3):289-297.
  7. National Kidney Foundation. KDOQI clinical practice guidelines and clinical practice recommendations for anemia in chronic kidney disease. Am J Kidney Dis. 2006;47(suppl 3):S11-S145.
  8. National Library of Medicine. MedlinePlus Medical Encyclopedia. Iron deficiency anemia. http://www.nlm.nih.gov/medlineplus/ency/article/000584.htm. Accessed September 1, 2008.
  9. CDC. Iron deficiency. http://www.cdc.gov/nccdphp/dnpa/nutrition/nutrition_for_everyone/iron_deficiency/index.htm. Accessed September 1, 2008.
  10. Drug Digest. Iron deficiency anemia. Available at: http://www.drugdigest.org/wps/portal/!ut/p/c1/. Accessed September 1, 2008.
  11. Fishbane S, Pollack S, Feldman HI, Joffe MM. Iron indices in chronic kidney disease in the National Health and Nutritional Examination Survey 1988-2004. Clin J Am Soc Nephrol. 2009;4(1):57-61.
  12. National Heart, Lung, and Blood Institute. Iron-deficiency anemia. http://www.nhlbi.nih.gov/health/dci/Diseases/ida/ida_whatis.html. Accessed June 19, 2009.
  13. Feraheme® (ferumoxytol) Injection For intravenous (IV) use Prescribing Information.
  14. Venofer® Prescribing Information.
  15. Ferrlecit® Prescribing Information.
  16. INFeD® Prescribing Information.
  17. Van Wyck DB, Roppolo M, Martinez CO, et al. A randomized, controlled trial comparing IV iron sucrose [Venofer®] to oral iron in anemic patients with non-dialysis dependent CKD. Kidney Int. 2005;68:2846–2856.
  18. Spinowitz BS, Kausz AT, Baptista J, et al. Ferumoxytol for treating iron deficiency anemia in CKD. J Am Soc Nephrol. 2008.
  19. Mircescu G, Garneata L, Capusa C, Ursea N. Intravenous iron supplementation for the treatment of anaemia in pre-dialyzed chronic renal failure patients. Nephrolol Dial Transplant. 2006;21:120–124.
  20. Gotloib L, Silverberg D, Fudin R, Shostak A. Iron deficiency is a common cause of anemia in chronic kidney disease and can often be corrected with intravenous iron. J Nephrol. 2006;19:161–167.
  21. Besarab A, Amin N, Ahsan M, et al. Optimization of epoetin therapy with intravenous iron therapy in hemodialysis patients. J Am Soc Nephrol. 2000;11:530–538.
  22. Silverberg DS, Blum M, Agbaria Z, et al. The effect of i.v. iron alone or in combination with low-dose erythropoietin in the rapid correction of anemia of chronic renal failure in the predialysis period. Clin Nephrol. 2001;55:212–219.
  23. Data on file. AMAG Pharmaceuticals, Inc.
  24. National Institute of Diabetes and Digestive and Kidney Diseases. Anemia in kidney disease. Available at: http://kidney.niddk.nih.gov/kudiseases/pubs/anemia/. Accessed September 1, 2008.

KDOQI is a trademark of the National Kidney Foundation.